PALM THERAPEUTICS, INC.
La Jolla, CA · Biotech · Private
Small molecule PPT1 replacement therapy (depalmitoylating molecules/DPALMs) for CLN1 neurodegenerative disease
palmtherapeutics.com →- Grants
- $1.2M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202020212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Targeted Depalmitoylation for the Treatment of NRas-Driven Melanoma | $585,110 | |
| Federal grant | Department of Health and Human Services · Phase I · Targeted Depalmitoylation for the Treatment of NRas-Driven Melanoma | $123,722 | |
| Federal grant | Department of Health and Human Services · Phase I · A Small Molecule Enzyme Replacement for the Treatment of CLN1 | $467,091 | |
| Federal grant | Department of Health and Human Services · Phase I · Targeted Depalmitoylation for the Treatment of NRas-Driven Melanoma | $61,500 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2449 | Ionetix Corp | — | $38M |
| 2450 | CALISTOGA PHARMACEUTICALS INC | — | $35M |
| 2451 | PROTEAN BIO INC. | — | — |
| 2452 | PALM THERAPEUTICS, INC. | — | — |
| 2453 | ILLUMINATE THERAPEUTICS, INC. | — | — |
| 2454 | TERAPORE TECHNOLOGIES, INC. | — | $3.5M |
| 2455 | Plexium | — | $60M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.